Comparison of Amyloid in Cerebrospinal Fluid, Brain Imaging, and Autopsy in a Case of Progressive Supranuclear Palsy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- ALZHEIMER DISEASE & ASSOCIATED DISORDERS34(3) · pp.275 · 2020
- 피인용
- Web of Science 2Scopus 2
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 2.098
- ISSN
- 0893-0341
저자
- 김경혜제1저자Departments of ∗ Neurology
- 서재득Departments of ∗ Neurology
- 김은수Anesthesia and Pain Medicine
- 김향숙Research Institute for Convergence of Biomedical Science and Technology
- 전수민Departments of ∗ Neurology
- 박경준Nuclear Medicine
- 이명준Departments of ∗ Neurology
- 이재혁Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
- 이영민Psychiatry
- 이강윤Psychiatry
- 신진홍Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
- 고준경# Neurosurgery
- 정나연Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
- 이재민# Neurosurgery
- 윤진아Rehabilitation Medicine Pusan National University Hospital Pusan National University School of Medicine and Biomedical Research Institute Busan
- 황청수Departments of †† Pathology
- 안재우Departments of †† Pathology
- 성석‡‡ Anatomy
- Spina, Salvatore§§ Department of Neurology Memory and Aging Center University of California San Francisco CA
- Seeley, William W.§§ Department of Neurology Memory and Aging Center University of California San Francisco CA
- 최경운Departments of †† Pathology
- 허기영∥∥ Forensic Medicine Pusan National University School of Medicine Yangsan Republic of Korea
- 김은주교신저자Departments of ∗ Neurology
초록
Cerebrospinal fluid (CSF) amyloid-beta 1-42 (A beta(1-42)) and amyloid positron emission tomography (PET) are the 2 main Alzheimer disease amyloid biomarkers that have been validated in neuropathologically confirmed Alzheimer disease cases. Although many studies have shown concordance of amyloid positivity or negativity between CSF A beta(1-42)and amyloid PET, several studies also reported discrepancies between these 2 A beta biomarkers. We conducted a comparison of CSF A beta(1-42)level, amyloid PET, and autopsy findings in a case with progressive supranuclear palsy in which biomarker acquisition and postmortem pathologic examination were conducted almost at the same time. Our case with antemortem CSF A beta(1-42)(+)/amyloid PET (-) who was pathologically confirmed with A beta pathology in the cerebral cortex may indicate CSF A beta(1-42)is more sensitive for assessing in vivo A beta than amyloid PET.
키워드
cerebrospinal fluid amyloid-betaamyloid positron emission tomographyautopsyALZHEIMERSBETA
식별자
- Scopus EID
- 2-s2.0-85089811293
- WoS UID
- 000570206400015



로그인
연구물 목록으로